【摘要】 目的分析骨转移瘤采用SPECT/CT融合图像与全身骨显像的价值。方法选择2018年1月—2019年1月我院接诊的可疑肿瘤骨转移性病变患者90例,所有患者均接受SPECT/CT融合图像与全身骨显像,90例患者的诊断结果通过病理学诊断与随访进行最终诊断。比较SPECT/CT融合图像与全身骨显像诊断骨转移瘤的效果。结果 90例可疑肿瘤骨转移性病变患者中,骨转移患者共68例(75.56%),良性病例共22例(24.44%)。共286例病灶,其中骨转移共213处(74.48%),其中良性病灶73处(25.52%)。SPECT/CT融合图像诊断灵敏度(92.96%)、特异性(54.79%)、准确性(83.22%)高于全身骨显像诊断灵敏度(85.45%)、特异性(38.36%)、准确性(73.43%),差异有统计学意义(P <0.05)。结论与全身骨显像诊断骨转移瘤结果相比,SPECT/CT融合图像诊断价值更高,值得在临床诊断中进行推广与使用。更多还原

【Abstract】 Objective To analyze the value of SPECT/CT fusion image and whole-body bone imaging in the treatment of bone metastases. Methods From January 2018 to January 2019, 90 patients with suspected tumor bone metastasis were selected. All patients received SPECT/CT fusion image and whole-body bone imaging. The final diagnosis was made by pathological diagnosis and follow-up. To compare the effect of SPECT/CT fusion image and whole-body bone imaging in the diagnosis of bone metastasis. Results 90 patients with suspected bone metastases, 68(75.56%) had bone metastases and 22(24.44%) had benign ones. There were 286 lesions, 213(74.48%) of which were bone metastases, 73(25.52%) of which were benign. The diagnostic sensitivity(92.96%), specificity(54.79%) and accuracy(83.22%) of SPECT/CT fusion image were higher than those of whole-body bone sensitivity(85.45%), specificity(38.36%) and accuracy(73.43%), the difference was statistically significant(P < 0.05). Conclusion Compared with the results of whole-body bone imaging in the diagnosis of bone metastases, SPECT/CT fusion image has higher diagnostic value, which is worth popularizing and using in clinical diagnosis.更多还原